Omada Health (OMDA) Cost of Revenue (2024 - 2026)

Omada Health has disclosed Cost of Revenue across 3 years of filings, most recently posting $24.0 million for Q2 2026.

• In Q2 2026, Cost of Revenue rose 14.16% year-over-year to $24.0 million; the TTM figure through Jun 2026 stood at $98.5 million (up 28.1% YoY), while the FY2025 annual figure was $89.3 million, up 33.39% from the prior year.
• Cost of Revenue came in at $24.0 million for Q2 2026 at Omada Health, down from $29.4 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $29.4 million in Q1 2026 to a low of $15.8 million in Q4 2024.
• Average Cost of Revenue over 3 years is $21.3 million, with a median of $22.2 million recorded in 2025.
• Year-over-year, Cost of Revenue jumped 40.01% in 2025 and gained 14.16% in 2026.
• Over 3 years, Cost of Revenue stood at $15.8 million in 2024, then soared by 40.01% to $22.2 million in 2025, then advanced by 8.4% to $24.0 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $24.0 million in Q2 2026, $29.4 million in Q1 2026, and $22.2 million in Q4 2025.